SC

Stork Capital

Europe, Geneve, Switzerland, Geneva

Description

Stork Capital is an asset manager that provides investment management services to its founders, private clients, and family offices.

Investor Profile

Stork Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (67%)
  • Series A (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Pharmaceutical
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Stork Capital frequently co-invest with?

Irving Investors
North America, Colorado, United States, Denver
Co-Investments: 1
BeiGene
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 3
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Kite Pharma
North America, California, United States, Los Angeles
Co-Investments: 2
CC
North America, New York, United States, New York
Co-Investments: 2
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 3
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 2

What are some of recent deals done by Stork Capital?

Shoreline Biosciences

La Jolla, California, United States

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.

BiotechnologyHealth CareLife ScienceMedical
Series BNov 2, 2021
Amount Raised: $140,000,000
Structure Therapeutics

South San Francisco, California, United States

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

BiotechnologyHealth CareMedicalPharmaceuticalProduct Research
Series BOct 20, 2021
Amount Raised: $100,000,000
Shoreline Biosciences

La Jolla, California, United States

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.

BiotechnologyHealth CareLife ScienceMedical
Series AFeb 7, 2021
Amount Raised: $43,000,000